论文部分内容阅读
据4月17日中央新闻联播报道:生物细胞免疫治疗取得重大进展,早期癌症三分之一可治愈。它是应用现代生物技术介导抑瘤和杀瘤效应的全新治疗方法。成为继手术、放疗,化疗之后解决肿瘤的第四“杀手”。洛阳市中心医院成功引进美国CLS生物技术,开展肿瘤生物免疫绿色治疗,成为地区唯一一家同时具备手术、放疗、化疗、生物免疫治疗能力的综合大型三级甲等医院,目前已有数百名患者接受了此项治疗。均获得满意治疗效
According to a report by the Central News Press on April 17, biological cell immunotherapy has made significant progress, and one-third of early cancers are curable. It is a brand-new treatment method that uses modern biotechnology to mediate tumor-inhibitory and tumoricidal effects. Become the fourth “killer” after surgery, radiotherapy, and chemotherapy to resolve the tumor. Luoyang Central Hospital successfully introduced American CLS biotechnology and launched green biological therapy for cancer. It became the only comprehensive large-scale tertiary A hospital with the capability of surgery, radiotherapy, chemotherapy, and biological immunotherapy in the region. Hundreds of patients have been accepted. This treatment. Have achieved satisfactory therapeutic effect